After a few months of eating only during certain hours, people with metabolic syndrome see a tiny but real drop in their average blood sugar levels over time.
Scientific Claim
Intermittent fasting reduces HbA1c by 0.08% in adults with metabolic syndrome over interventions averaging 3 months, suggesting a small but statistically significant improvement in long-term glucose regulation.
Original Statement
“glycosylated hemoglobin reduced by 0.08 (95% CIs: −0.25; −0.10)”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
RCT-based meta-analysis supports causal inference. The claim reflects the reported effect size and confidence interval accurately without overstatement.
Evidence from Studies
Supporting (1)
Unknown Title
This study found that people with metabolic syndrome who tried intermittent fasting lowered their HbA1c (a measure of long-term blood sugar) by 0.08%, which is a small but real improvement in how well their body controls sugar over time.